Richard Thompson

Richard Thompson is a Visiting Professor at the School of Cardiovascular & Metabolic Health. His research focuses on advanced stroke treatment protocols, particularly the application of thrombolytic therapies for intraventricular hemorrhage management. He has contributed to pivotal clinical trials such as the CLEAR III trial, investigating the efficacy of thrombolytic agents in severe stroke cases.

Education details are not provided in the text, but his work demonstrates expertise in neurology and clinical trial design. No scientific awards or grants are explicitly mentioned. He has not listed advisees or students here. His affiliation with the School of Cardiovascular & Metabolic Health suggests involvement in multidisciplinary cardiovascular and metabolic health initiatives.